CAPITAL SOUTHWEST CORP
CSWCSync financial data to generate a health grade for this company.
Analytical Summary
On an absolute basis, CAPITAL SOUTHWEST CORP shows solid but mixed fundamentals. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
32-Year Financial Trajectory
Quarterlyinfo Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Dividend History
Dividend / share · sourced from SEC filingsStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q4 FY2027 Mar 31, 2018 10-K ↗ | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Mar 31, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Mar 31, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Jun 30, 2012 10-Q ↗ | Q4 FY2021 Mar 31, 2021 10-K ↗ | Q3 FY2021 Dec 31, 2011 10-Q ↗ | Q2 FY2021 Sep 30, 2011 10-Q ↗ | Q1 FY2021 Mar 31, 2012 10-Q ↗ | Q4 FY2020 Mar 31, 2011 10-K ↗ | Q3 FY2020 Dec 31, 2010 10-Q ↗ | Q2 FY2020 Sep 30, 2010 10-Q ↗ | Q1 FY2020 Mar 31, 2011 10-Q ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q1 FY2019 Mar 31, 2010 10-Q ↗ | Q4 FY2018 Mar 31, 2009 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
21.3%
Excellent
↓
Excellent
Declining
Year-over-year change in total revenue
Optimal:
> 10%
|
— |
138.1%
Excellent
↑
Excellent
Improving
Year-over-year change in total revenue
Optimal:
> 10%
|
8.0%
Fair
Fair
Year-over-year change in total revenue
Optimal:
> 10%
|
-59.7%
Weak
Weak
Year-over-year change in total revenue
Optimal:
> 10%
|
— | — | — | — | — | — | — |
| EPS Growth YoY (%) | — |
35.3%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
67.6%
Excellent
↓
Excellent
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-4.2%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-20.6%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
3300.0%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-51.4%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-30.4%
Weak
→
Weak
Stable
Year-over-year change in earnings per share
Optimal:
> 10%
|
-3.1%
Weak
↑
Weak
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-98.5%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
12.9%
Fair
↓
Fair
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
32.7%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
32.7%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
30.0%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
21.6%
Good
Good
Year-over-year change in earnings per share
Optimal:
> 10%
|
20.9%
Good
Good
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income Growth YoY (%) | — |
56.5%
Excellent
↓
Excellent
Declining
Year-over-year change in net income |
102.2%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
12.9%
Fair
↓
Fair
Declining
Year-over-year change in net income |
92.4%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
30.4%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-30.7%
Weak
↓
Weak
Declining
Year-over-year change in net income |
0.3%
Caution
↓
Caution
Declining
Year-over-year change in net income |
-41.1%
Weak
↓
Weak
Declining
Year-over-year change in net income |
-25.9%
Weak
↓
Weak
Declining
Year-over-year change in net income |
696.3%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
139.2%
Excellent
↓
Excellent
Declining
Year-over-year change in net income |
848.7%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-7.6%
Weak
↑
Weak
Improving
Year-over-year change in net income |
-80.5%
Weak
Weak
Year-over-year change in net income |
-37.5%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FCF Growth YoY (%) | — | — |
52.8%
Excellent
↑
Excellent
Improving
Year-over-year change in free cash flow |
-149.3%
Weak
Weak
Year-over-year change in free cash flow |
-16.7%
Weak
Weak
Year-over-year change in free cash flow |
— | N/M |
58.1%
Excellent
Excellent
Year-over-year change in free cash flow |
N/M | — | N/M |
-33.6%
Weak
↓
Weak
Declining
Year-over-year change in free cash flow |
46.0%
Excellent
↑
Excellent
Improving
Year-over-year change in free cash flow |
— |
-107.4%
Weak
Weak
Year-over-year change in free cash flow |
87.8%
Excellent
Excellent
Year-over-year change in free cash flow |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS CAGR 3Y (%) | — |
-10.9%
Weak
↓
Weak
Declining
Compound annual EPS growth over 3 years |
-2.8%
Weak
↑
Weak
Improving
Compound annual EPS growth over 3 years |
-4.0%
Weak
↑
Weak
Improving
Compound annual EPS growth over 3 years |
0.7%
Caution
↑
Caution
Improving
Compound annual EPS growth over 3 years |
-12.1%
Weak
↓
Weak
Declining
Compound annual EPS growth over 3 years |
-12.6%
Weak
Weak
Compound annual EPS growth over 3 years |
3.7%
Caution
Caution
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2027 Mar 31, 2018 10-K ↗ | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Mar 31, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Mar 31, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Jun 30, 2012 10-Q ↗ | Q4 FY2021 Mar 31, 2021 10-K ↗ | Q3 FY2021 Dec 31, 2011 10-Q ↗ | Q2 FY2021 Sep 30, 2011 10-Q ↗ | Q1 FY2021 Mar 31, 2012 10-Q ↗ | Q4 FY2020 Mar 31, 2011 10-K ↗ | Q3 FY2020 Dec 31, 2010 10-Q ↗ | Q2 FY2020 Sep 30, 2010 10-Q ↗ | Q1 FY2020 Mar 31, 2011 10-Q ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q1 FY2019 Mar 31, 2010 10-Q ↗ | Q4 FY2018 Mar 31, 2009 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF Margin (%) (%) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
202.6%
Excellent
Excellent
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — |
-322.6%
Weak
↓
Weak
Declining
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-114.6%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-85.0%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — | — | — |
| FCF / Net Income (x) | — |
-2.15x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.85x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.78x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.12x
Fair
↑
Fair
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.37x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-10.24x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.07x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.22x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-7.58x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.77x
Caution
↑
Caution
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.16x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.34x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.85x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-33.26x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.72x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-27.87x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.32x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.33x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-11.22x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2027 Mar 31, 2018 10-K ↗ | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Mar 31, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Mar 31, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Jun 30, 2012 10-Q ↗ | Q4 FY2021 Mar 31, 2021 10-K ↗ | Q3 FY2021 Dec 31, 2011 10-Q ↗ | Q2 FY2021 Sep 30, 2011 10-Q ↗ | Q1 FY2021 Mar 31, 2012 10-Q ↗ | Q4 FY2020 Mar 31, 2011 10-K ↗ | Q3 FY2020 Dec 31, 2010 10-Q ↗ | Q2 FY2020 Sep 30, 2010 10-Q ↗ | Q1 FY2020 Mar 31, 2011 10-Q ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q1 FY2019 Mar 31, 2010 10-Q ↗ | Q4 FY2018 Mar 31, 2009 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) | — |
2.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.3%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.7%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.0%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.0%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.8%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.8%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.3%
Weak
→
Weak
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.4%
Weak
→
Weak
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.7%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.1%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — |
4.7%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2027 Mar 31, 2018 10-K ↗ | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Mar 31, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Mar 31, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Jun 30, 2012 10-Q ↗ | Q4 FY2021 Mar 31, 2021 10-K ↗ | Q3 FY2021 Dec 31, 2011 10-Q ↗ | Q2 FY2021 Sep 30, 2011 10-Q ↗ | Q1 FY2021 Mar 31, 2012 10-Q ↗ | Q4 FY2020 Mar 31, 2011 10-K ↗ | Q3 FY2020 Dec 31, 2010 10-Q ↗ | Q2 FY2020 Sep 30, 2010 10-Q ↗ | Q1 FY2020 Mar 31, 2011 10-Q ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q1 FY2019 Mar 31, 2010 10-Q ↗ | Q4 FY2018 Mar 31, 2009 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) | — |
1.12x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.08x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.09x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.01x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.08x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — |
0.95x
Fair
Fair
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — |
1.06x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt (USD) | — | $1.10B | $1.03B | $947.33M | $879.06M | $912.84M | $-36.01M | $-47.24M | $702.14M | $-32.27M | — | — | $650.98M | $-21.59M | — | — | — | — | — | — | $-65.73M | — | — | — | $-34.67M | $-45.50M | — | — | $-78.00M | — | $-4.09M | $-14.72M |
| Metric | Q4 FY2027 Mar 31, 2018 10-K ↗ | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Mar 31, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Mar 31, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Jun 30, 2012 10-Q ↗ | Q4 FY2021 Mar 31, 2021 10-K ↗ | Q3 FY2021 Dec 31, 2011 10-Q ↗ | Q2 FY2021 Sep 30, 2011 10-Q ↗ | Q1 FY2021 Mar 31, 2012 10-Q ↗ | Q4 FY2020 Mar 31, 2011 10-K ↗ | Q3 FY2020 Dec 31, 2010 10-Q ↗ | Q2 FY2020 Sep 30, 2010 10-Q ↗ | Q1 FY2020 Mar 31, 2011 10-Q ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q1 FY2019 Mar 31, 2010 10-Q ↗ | Q4 FY2018 Mar 31, 2009 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LT Debt (USD) | — | $1.13B | $1.07B | $1.03B | $925.95M | $956.07M | — | — | $735.44M | — | — | — | $672.26M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total Equity (USD) | — | $1.01B | $995.63M | $947.00M | $916.47M | $883.63M | $830.44M | $791.26M | $777.33M | $755.68M | $720.97M | $657.77M | $636.20M | $590.41M | — | — | — | $420.87M | — | — | — | $336.25M | — | — | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2027 Mar 31, 2018 10-K ↗ | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Mar 31, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Mar 31, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Jun 30, 2012 10-Q ↗ | Q4 FY2021 Mar 31, 2021 10-K ↗ | Q3 FY2021 Dec 31, 2011 10-Q ↗ | Q2 FY2021 Sep 30, 2011 10-Q ↗ | Q1 FY2021 Mar 31, 2012 10-Q ↗ | Q4 FY2020 Mar 31, 2011 10-K ↗ | Q3 FY2020 Dec 31, 2010 10-Q ↗ | Q2 FY2020 Sep 30, 2010 10-Q ↗ | Q1 FY2020 Mar 31, 2011 10-Q ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q1 FY2019 Mar 31, 2010 10-Q ↗ | Q4 FY2018 Mar 31, 2009 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $1.45M | — | $5.62M | $1.26M | $1.20M | $1.08M | $2.36M | $1.16M | $2.97M | — | — | — |
| Depreciation Expense (USD) | — | $1.76M | $1.77M | $1.75M | $1.68M | $1.67M | $1.59M | $1.32M | $1.28M | $1.18M | $1.19M | $1.16M | $779.00K | $748.00K | $674.00K | $677.00K | $651.00K | $602.00K | $541.00K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income, GAAP (USD) | — | $27.48M | $32.90M | $25.62M | $27.00M | $17.56M | $16.27M | $22.68M | $14.04M | $13.47M | $23.48M | $22.62M | $23.81M | $18.18M | $2.95M | $9.46M | $2.51M | $19.67M | $15.14M | $15.14M | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Cash Flow (USD) | — | $-59.14M | $-93.63M | $-71.22M | $30.49M | $-58.73M | $-165.82M | $-23.83M | $31.12M | $-102.09M | $18.01M | $-48.79M | $-55.63M | $-33.45M | $-98.09M | $-25.75M | $-69.80M | $-43.57M | $-35.31M | $-169.94M | $66.15M | $-88.87M | $11.39M | $18.55M | $-9.32M | $-3.47M | $-2.71M | $-989.00K | $75.40M | — | — | — |
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare CSWC with peers
Stack CSWC against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 10 years · 32 quarters